长沙 [切换城市] 长沙招聘长沙生物/制药/医疗器械招聘长沙医药技术研发管理人员招聘

Associate Scientist(职位编号:JV105)

海正辉瑞制药有限公司

  • 公司规模:1000-5000人
  • 公司性质:合资(欧美)
  • 公司行业:制药/生物工程

职位信息

  • 发布日期:2014-07-17
  • 工作地点:杭州-富阳市
  • 招聘人数:2
  • 语言要求:英语熟练
  • 职位月薪:面议
  • 职位类别:医药技术研发人员  医药技术研发管理人员

职位描述

JOB TITLE : Associate Scientist

REPORT TO (TITLE): Manager / Senior Scientist

JOB SUMMARY:
The Associate Scientist will take an active role in supporting drug development by applying a variety of analytical methodologies to support physical and chemical characterization of drug substances (including raw materials and intermediates) and drug products. Working knowledge of analytical (e.g., HPLC-MS, GC-MS, spectroscopy) and physical (e.g., dissolution) techniques used for the characterization of pharmaceutical substances and products is desired.


KEY RESULT AREAS & JOB ACTIVITIES /TASKS:
1.Responsible for performing laboratory work in support of analytical testing of pharmaceutical projects

2.Responsibilities may include analytical method development and validation; stability and release testing; testing to support pharmaceutical development efforts; direct interaction with project team members, including presentation of data; critical review of data; preparation of technical reports

3. Responsible for effectively using a wide-variety of software and information systems

EDUCATION & EXPERIENCE REQUIREMENTS:

BS/MS in analytical chemistry or a related field with 0-2 years of relevant experience

COMPETENCIES REQUIREMENTS:
1.Experience with any of the following analytical methodologies: chromatography, Karl Fischer Titration, dissolution, mass spectrometry

2.Effective interpersonal, teamwork and communication skills (written and oral)

3.Ability to listen, learn and perform experimentation with minimal supervision

4.Attention to detail, strong organizational skills, and the ability to multitask

5. Good problem-solving and trouble-shooting skills

公司介绍

2012年5月18日,辉瑞制药有限公司与海正制药签署了正式合资经营协议。在获得有关部门的批准后,双方拟建立的合资公司(“海正-辉瑞制药有限公司”)即将正式成立。而合资公司的筹建工作也已紧锣密鼓地展开。辉瑞与海正拥有共同的目标,即共同打造一家一流的中国制药公司,以世界标准运营,为中国和全球市场提供最高质量的品牌制药。为了打造坚实的发展基础,双方将向合资企业注入经过挑选的产品、生产场地、现金和其他相关资产。